-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

T-Cell Redirection Therapy for Multiple Myeloma (ticketed session for in-person participants)

Program: How I Treat: Bringing Science to Clinical Dilemmas
Sunday, December 10, 2023: 8:00 AM-9:00 AM
Aqua Salon E (Hilton San Diego Bayfront)
Surbhi Sidana, MD, Stanford University
Sidana: Magenta Therapeutics, BMS, Janssen, Sanofi, Oncopeptides, Takeda, Pfizer: Consultancy; Magenta Therapeutics, BMS, Allogene, Janssen, Novartis: Research Funding.